Search This Blog
Translate
Pages
خلفيات وصور / wallpapers and pictures images / fond d'écran photos galerie / fondos de pantalla en i
Buscar este blog
11/4/23
American Academy of Pediatrics.)
Chapter 29 ■ Umbilical Artery Catheterization 163
(2) Position infant on side with same side elevated
as artery being catheterized. Flex hip.
(3) Instill lidocaine as for E23b (3). Do not force
e. Easy insertion, but no blood return
(1) Catheter is outside vessel in false channel.
(2) Remove and observe infant carefully for evidence of complication.
24. Place marker tape on catheter with base of tape flush
with surface of cord so that displacement of the catheter
25. Remove umbilical tape and place purse-string suture
around base of the cord (not through skin or vessels).
Three bites into cord (with needle facing away from
catheter) are sufficient to include all three vessels
If desired, form marker tape into bilateral wings, and
sew the tails of the purse-string suture through the
wings to anchor the catheter in a symmetrical fashion.
This is a useful method in very small premature infants
because it avoids sticking tape to the abdominal wall
(27). Alternatively, remove needle and wrap ends of
suture in opposite direction around catheter for about
3 cm and tie, taking care not to kink catheter.
26. Secure catheter temporarily by looping over upper
27. Obtain radiographs or ultrasound to check catheter
a. Catheter tip above T6 or between T10 and L2
(1) Measure distance between actual and appropriate position on radiograph.
(2) Withdraw equal length of catheter.
(3) Repeat radiographic study.
(2) Never advance catheter once in situ, because
this will introduce a length of contaminated
28. If desired, secure catheter with tape bridge (Fig. 38.14).
29. Continue routine cord care with 70% alcohol swab or
30. Stabilize catheter, stopcock, and syringe, using tongue
a. Reduces risk of air embolus if syringe is maintained
b. Prevents accidental disconnection of catheter
This method is usually successful even after failed insertion
through the umbilical stump, as there is less tendency for
false tracts. The most frequent reason for failed umbilical
artery cutdown is mistaking the urachus for a vessel.
Because of the time and risks associated with the cutdown
procedure, standard insertion should be attempted first.
1. Same as for umbilical artery catheterization by conventional technique
1. Same as for umbilical artery catheterization by conventional technique.
2. 1% lidocaine HCl without epinephrine in 3-mL syringe
3. No. 15 surgical blade and holder
4. Curved delicate dressing forceps, two pairs (1/4 or 1/2
6. Self-retaining retractor (such as eyelid retractor)
8. Absorbable suture on small cutting needle
1. Same as described earlier for conventional technique.
3. Ensure that abdominal incision is on abdominal wall
and not too close to umbilical stump.
4. Identify landmarks carefully to avoid cutting or catheterizing urachus.
5. When incising mesenchymal sheath, take care to avoid
6. Secure the catheter with an internal ligature that is just
tight enough to prevent accidental removal but loose
enough for elective removal or reinsertion, in case
the catheter becomes occluded by thrombus or precipitate.
1. Insert an orogastric tube to keep the bowel as decompressed as possible.
2. Prepare infant and drape as for umbilical artery catheterization (see earlier in chapter).
3. If catheter has been left in place after previous attempt,
include vessel and catheter in the preparation, leaving
the catheter accessible for removal.
164 Section V ■ Vascular Access
4. Anesthetize area of skin immediately below umbilicus,
at umbilical stump–abdominal wall junction, with
recommended for standard insertion, as cutdown catheter will enter vessel farther along course.
6. Make a smile-shaped incision from 4 to 8 o’clock
through the skin of the abdominal wall at the junction
7. Place self-retaining retractor to maintain exposure.
8. Using blunt dissection through the subcutaneous tissue
with mosquito forceps, identify the fascia overlying the
urachus and umbilical vessels.
barely perceptible in extremely premature infants, in
term infants it may be thick enough to require making
an incision through the sheath prior to blunt dissection.
9. While elevating the fascia with two forceps, make a
small incision between their tips. Enlarge incision with
10. With curved mosquito forceps, dissect in the midline
and identify the urachus (Fig. 29.13).
The urachus is a white, glistening, cordlike structure
view. The umbilical arteries lie posterolaterally on
either side but not touching the urachus.
11. Identify the umbilical arteries lying to either side of the
162 Section V ■ Vascular Access
20. Insert catheter into lumen of artery, between prongs of
dilating forceps (Fig. 29.11).
Grasp cord again with toothed tissue forceps and pull
gently toward head of infant. This mild traction will
facilitate passage of catheter at an angle between the
22. After passing the catheter approximately 5 cm, aspirate
to verify intraluminal position. Clear blood by injecting
0.5 mL of flush solution. Advance catheter to calculated appropriate length.
23. Take appropriate action if insertion is complicated (Fig.
a. Resistance before tip reaches abdominal wall
(<3 cm from surface of abdominal stump)
b. “Popping” sensation rather than “relaxation”
(1) Catheter may have exited lumen and created a
(2) Remove and use second artery.
(3) If unsuccessful, draw 0.5 mL of lidocaine from
vial. Reinsert tip of catheter approximately 2 cm
into UAC and drip lidocaine into vessel. Apply
constant gentle pressure until vessel dilates.
c. Backflow of blood, particularly around vessel
(2) Catheter may be in false channel, with extravascular bleeding.
d. Resistance is encountered at anterior abdominal wall
or sharp turn in vessel as it angles around bladder
toward internal iliac artery (approximately 6 to 8 cm
from surface of umbilical stump in 2- to 4-kg neonate).
160 Section V ■ Vascular Access
a. Tighten only enough to prevent bleeding and, if
possible, place around Wharton jelly rather than
b. It may be necessary to loosen the tie when inserting
9. Cut cord horizontally with scalpel (Fig. 29.8).
a. Approximately 1 to 1.5 cm from skin
Bloom et al. (25) described an alternative
approach to the artery with lateral arteriotomy. To
(1) Clamp across end of cord with a mosquito
hemostat in the nondominant hand and pull
firmly toward the infant’s head.
(2) Roll cord 180 degrees over hemostat toward
(3) Identify arteries in superior right and left lateral
(4) Approximately 1 cm from abdominal wall,
incise Wharton jelly down to arterial wall, using
(5) Incise artery through half of circumference. If
necessary, dilate lumen with iris forceps.
(6) Insert catheter into lumen of artery, directed in a
caudad direction, for predetermined distance.
10. Control bleeding by gentle tension on umbilical tape.
12. Identify cord vessels (Fig. 29.9).
the 12-o’clock position at the base of the umbilical
b. Arteries are smaller, thick-walled, and white and
may protrude slightly from cut surface.
c. Omphalomesenteric duct is rarely present.
Fig. 29.8. Traction is being placed on cord in direction of the
arrow. Operator is about to make a horizontal cut across cord.
usually corresponds to the aortic bifurcation.
Chapter 29 ■ Umbilical Artery Catheterization 161
13. Grasp cord stump, using toothed forceps, at point close
to (but not on) artery to be catheterized. If available, it
may be helpful to have an assistant scrub and assist.
a. Apply two curved mosquito hemostats to Wharton
jelly on opposite sides of the cord, away from the
b. Apply traction to stabilize cord stump.
14. Introduce one of the points of the curved iris forceps
into the lumen of the artery and probe gently to a depth
15. Remove forceps and bring points together before introducing them once more into the lumen.
16. Probe gently to a depth of 1 cm (up to the curved
“shoulder” of the forceps), keeping the points together.
17. Allow the points to spring apart, and maintain forceps
in this position for 15 to 30 seconds to dilate vessel
(Fig. 29.10). Time spent in ensuring dilatation prior
to catheter insertion increases the likelihood of
18. Release cord and set aside toothed forceps, while keeping curved forceps within artery.
19. Grasp catheter 1 cm from tip, between free thumb and
forefinger or with curved iris forceps.
Fig. 29.9. The vessels of the umbilical cord. Thin-walled
umbilical vein at 12-O’clock position is indicated by a white arrow.
One of the two umbilical arteries is to the right and directly below
Fig. 29.10. An iris forceps is pointed into the umbilical artery
in order to dilate the lumen of the artery.
is secured in place. B: Close-up photo of the umbilical stump with the arterial catheter in place.
Chapter 29 ■ Umbilical Artery Catheterization 159
a. High position (14,19): Level of thoracic vertebrae
T6–T9 (Fig. 29.6); catheter tip above origin of celiac
b. Low position (14,19): Level of lumbar vertebrae L3–
(1) Catheter tip is below major aortic branches such
(2) In most newborns, this position coincides with
the aortic bifurcation at the upper end of the
2. Make external measurements as necessary to estimate
length of catheter to be inserted (see Figs. 29.1–29.3)
3. Prepare as for major procedure (see Chapter 5).
4. Attach stopcock to hub of catheter and fill system with
flush solution. Turn stopcock to catheter “off.”
5. Place sterile gauze around umbilical stump and elevate
out of sterile field or have an ungloved assistant grasp
the cord by the cord clamp or forceps and pull the cord
vertically out of the sterile field.
chlorhexidine in infants <2 months of age is not recommended (24).
7. Drape area surrounding cord.
8. Place umbilical tie around umbilicus and tie loosely
Fig. 29.5. The aorta and branches.
3. Take time and care to dilate lumen artery before
attempting to insert catheter.
4. Catheter should not be forced past an obstruction.
5. Never advance catheter once placed and secured.
7. Avoid covering the umbilicus with dressing. Dressing may
delay recognition of bleeding or catheter displacement.
8. Always obtain radiographic (including a lateral view) or
ultrasound (15) confirmation of catheter position.
because hemorrhage may go unrecognized.
Fig. 29.1. Graph for determination of length of catheter to be
inserted for appropriate low aortic or venous placement. Length of
catheter is measured from umbilical ring. Length of umbilical
stump must be added. The shoulder–umbilicus distance is the
perpendicular distance between parallel horizontal lines at the
level of the umbilicus and through the distal ends of the clavicles.
(Adapted from Dunn P. Localization of the umbilical catheter
by postmortem measurement. Arch Dis Child. 1966;41:69, with
158 Section V ■ Vascular Access
10. Take care not to allow air to enter the catheter. Always
11. When removing catheter, cut suture at skin, not on
catheter, to avoid catheter transection.
E. Technique (See also Umbilical
their origins are 2 to 3 mm. As they approach the umbilicus,
iliac artery. Occasionally, it will pass into the femoral artery
via the external iliac artery or into one of the gluteal
arteries. The latter two sites are unsuitable for sampling,
pressure measurement, or infusion.
1. Placement of UAC in high position should be used
High position is associated with fewer episodes of
blanching and cyanosis of the lower extremities (18).
High catheters were found to have decreased incidence
of clinical vascular complications with a relative risk of
0.53 (95% confidence interval, 0.44 to 0.63) with no
Fig. 29.3. Estimates of insertion length of umbilical catheters
(umbilical artery catheter tip inserted between T6 and T10;
umbilical vein catheter tip inserted above diaphragm in inferior
vena cava near right atrium) based on birthweight (BW) (with
(top) and umbilical vein length = 1.5 BW + 5.6 (bottom), where
1986;140:787, with permission.)
g. 5-French (Fr) gauge for infants weighing >1,200 g
h. 3.5-Fr gauge for infants weighing <1,200 g
5. Three-way stopcock with Luer-Lock
7. 0.45 to 0.9 normal saline (NS) flush solution (saline
In very small premature infants, particularly in the
using 0.45 NS rather than more concentrated saline
solutions in these infants. The use of hypotonic (0.25
NS) or dextrose solutions has been associated with
hemolysis of red blood cells and should be avoided if
incidence of fibrin thrombus formation in the catheter
lumen. Horgan et al. (9) found that the use of 1 U/mL
heparin did not reduce the incidence of umbilical
artery catheter (UAC)-related thrombi but did lower the
Chapter 29 ■ Umbilical Artery Catheterization 157
rate of infusion from 1 to 2 mL/h (heparin 1 U/mL), and
Bosque and Weaver (11) showed that continuous infusion
of 1 U/mL heparin is more effective than intermittent
infusion in maintaining patency of the UAC. More
recent data have indicated that heparin decreases the
incidence of thrombotic complications (12), and a
Cochrane Database Review found that the use of as little
as 0.25 U/mL heparin in the infusate decreases the likelihood of line occlusion (13).
10. No. 11 scalpel blade and holder
12. Two curved mosquito hemostats
14. Two curved, nontoothed iris forceps
15. 2% lidocaine HCl without epinephrine
16. 3-mL syringe and needle to draw up lidocaine
18. 4-0 silk suture on small, curved needle
1. Avoid use of feeding tubes as catheter (associated with
higher incidence of thrombosis) (14).
Chapter 28 ■ Management of Extravasation Injuries 155
1. Wilkins CE, Emmerson AJB. Extravasation injuries in regional
neonatal units. Arch Dis Child Fetal Neonatal Ed. 2004;89:F274.
3. Friedman J. Plastic surgical problems in the neonatal intensive
care unit. Clin Plast Surg. 1998;25:599.
5. Zenk KE, Dungy CI, Greene GR. Nafcillin extravasation injury.
Use of hyaluronidase as an antidote. Am J Dis Child. 1981;135:1113.
6. Subhani M, Sridhar S, DeCristafaro JD. Phentolamine use in a
7. Amjad I, Murphy T, Nylander-Householder L, et al. A new
approach to management of intravenous infiltration in pediatric
patients. J Infusion Nurs. 2011;34:242.
9. Doellman D, Hadaway L, Bowe- Geddes LA, et al. Infiltration
and extravasation: update on prevention and management. J
11. Chandavasu O, Garrow D, Valda V, et al. A new method for the
prevention of skin sloughs and necrosis secondary to intravenous
infiltration. Am J Perinatol. 1986;3:4.
13. Fox MD. Wound care in the neonatal intensive care unit.
14. Gault DT. Extravasation injuries. Br J Plast Surg. 1993;46:91.
15. Kuenstig LL. Treatment of intravenous infiltration in a neonate.
J Pediatr Health Care. 2010;24:184.
16. Denkler KA, Cohen BE. Reversal of dopamine extravasation
injury with topical nitroglycerine ointment. Plast Reconstruct
19. Cisler-Cahill L. A protocol for the use of amorphous hydrogel to
support wound healing in neonatal patients: an adjunct to nursing care. Neonatal Netw. 2006;25:267.
20. Rustogi R, Mill J, Fraser JF, et al. The use of Acticoat in neonatal
Labels
- |اختصارات_طبية
- alcohol
- anemia
- blood
- Calcium
- Cirugía en la clínica de pequeños animales Cirugía sin sangrado
- Cómo Controlar la Ansiedad y los Ataques de Pánico
- Cytolytic treatment of malignancies
- Davidson's Self-assessment in Medicine
- General Surgical Emergencies
- Goodman_&_Gilman's_The_Pharmacological_Basis_of_Therapeutics 13th
- Hypoglycemia
- Literatura
- Macleod’s Clinical Examination
- mcq general
- Nephrotic syndrome
- oxidation
- physical or emotional
- plasma
- Products
- The hydrogen peroxide
- Voto Cautivo
- اخبار بوك سيت
- اسلاميات
- تاريخ
- خلفيات وصور / wallpapers and pictures images / fond d'écran photos galerie / fondos de pantalla en imágenes
- علم الادوية
- قصائد واشعار
- قصص . بوك سيت
- مال واعمال
- مجتمع
- معلومات . بوك سيت
Popular Posts
-
بالنسبة لهذا البروتين العجيب المحير أبو ضحكة مميتة انه ال AFP ياسادة ألفا فيتو بروتين وممكن تقول عليه AFP Total AFP AFP-L3% Alpha-fetoprot...
-
المشي ليس مجرد تحريك قدم أمام الأخرى . بل تبين أنه يحمل الكثير من التغيرات الجيدة في كل مرة يُمارس فيها المشي. الدقيقة 1-5 الخطوات الأولى في...
-
1 ـ نيجيريا 205,542,168 2 ـ اثيوبيا 114,630,633 3 ـ مصر 102,115,130 4 ـ الكونغو الديموقراطية 89,234,236 5 ـ تانزانيا 59,531,669 6 ـ إفر...
-
يعتبر لومينير الأسنان واحدًا من الحلول الثورية التي حملها لنا تخصص تجميل الأسنان كتطورٍ للأنواع المختلفة لعمليات ووسائل تبييض الأسنان والقضا...
-
اندول 1000 مجم قرص فوار عرض مربع 8 الجرعة 1000 مجم الموزع أو الصانع كوبر فارما التركيبة باراسيتامول الدرجة العلاجية مسكن - خافض للحرارة
-
ميبستان -يوجد بشكل مضغوطات وشرابات مادته الفعالة حمض المفيناميك تأثيره الدوائي : مسكن ألم خافض حرارة مضاد التهاب. يستعمل بحالا...
-
أكوبان 20 ملغ ، محلول للحقن عرض علبة بها 5 أمبولات 2 مل الجرعة 20 ملغ برينسيبس نعم الموزع أو الصانع مافار التركيبة نيفوبام الدرجة العلاجية ...
-
سيليفي 200 ملغ ، كبسولة جديد عرض مربع 10 الجرعة 200 ملجم الموزع أو الصانع PHI التركيبة سيليكوكسيب الدرجة العلاجية عقار مضاد للالتهابات (مضا...
-
الشكوى من الم الظهر مسألة شائعة جدًا. ويعتبر الم الظهر، السبب الأكثر انتشارا للتوجه للعلاج الطبي وللتغيب عن العمل. الأنباء المشجعة هي أنه...
-
فوكسسيب 200 مجم كبسولة جديد عرض علبة 20 الجرعة 100 مجم الموزع أو الصانع نوفوفارما التركيبة سيليكوكسيب الدرجة العلاجية عقار مضاد للالتهابات (...
Popular Posts
-
TORONTO NOTES Common Acronyms and Abbreviations Used in Medicine Common Unit Conversions Commonly Measured Laboratory Values Ethical, Legal...
-
"Now, by the power of God! for the sake of the Queen, and the British people, and yourselves, I cannot continue my dislike against th...
-
ABSTRACT BACKGROUND: Neoadjuvant trastuzumab/pertuzumab (HP) plus chemotherapy for HER2-positive breast cancer (BC) achieved promising eff...
-
Treatment • fluid resuscitation, NG tube decompression • surgery: enterolithotomy and removal of stone, inspect small and large bowel for ...
-
Principe (s) actif (s) Acides Aminés, Hyaluronate de Sodium Forme (s) galénique (s) Collutoire Classe (s) thérapeutique (s) Oncologie Indi...
-
▶ Sinusitis (acute), 513 Notifiable diseases, 506 Novofem, 763 Novogel, 1594 NovoMix preparations, 716 NovoPen 4, 723 NovoRapid preparations...
-
l TREATMENT CESSATION The dose should preferably be reduced gradually over about 4 weeks, or longer if withdrawal symptoms emerge (6 months ...
Popular Posts
-
ABSTRACT PURPOSE: To define a set of biomarkers that can be used to identify patients at high risk of developing late DOX-induced cardiac ...
-
ABSTRACT Venous thromboembolism (VTE) continues to cause significant morbidity and excess mortality in patients with multiple myeloma. The...
-
كيف نعرف ان طفلنا لديه تضخم لحميات (ناميات) : عادة ما تحدث تضخم لحمية البلعوم الأنفي (الناميات) عند الاطفال الذين تتراوح اعمارهم بين 1,5 ال...
-
ABSTRACT INTRODUCTION: Complications after gynecological surgery in Sweden are registered in the well-established Swedish National Quality...
-
المادتين vasodilation(موسع للأوعية الدموية) لكن بيختلفوا في الميكانزم ايزوزوربايد ثنائي النتراتisosorbide dinitrates بيشتغل vasodilation ...
-
الحالات هي . تحفيز عملية الولادة الطبيعية (induction of labour) . اكمال خروج الطفل في عمليات الاسقاط التي تحدث سواء كان الاسقاط الميت في ب...
-
Typical Choroid Plexus Papilloma KEY FACTS TERMINOLOGY • Choroid plexus tumor (CPT) ○ 3 types of CPTs – Choroid plexus papilloma (CPP) (WH...
-
الفُواق أو الحازوقة هي عبارة عن انقباضات سريعة (ارتجافات) غير إرادية تصيب الحجاب الحاجز تتزامن مع رد فعل عكسي متمثل باغلاق لسان المزمار في ا...
-
الإكزيما والبهاق والصدفية والهيربس.. أشهر أمراض جلدية تصيب العضو الذكري العدوى الجلدية قد تمتد إلى الأعضاء الخارجية التناسلية عند الرجل * ...
Popular Posts
-
TORONTO NOTES Common Acronyms and Abbreviations Used in Medicine Common Unit Conversions Commonly Measured Laboratory Values Ethical, Legal...
-
"Now, by the power of God! for the sake of the Queen, and the British people, and yourselves, I cannot continue my dislike against th...
-
ABSTRACT BACKGROUND: Neoadjuvant trastuzumab/pertuzumab (HP) plus chemotherapy for HER2-positive breast cancer (BC) achieved promising eff...
-
Treatment • fluid resuscitation, NG tube decompression • surgery: enterolithotomy and removal of stone, inspect small and large bowel for ...
-
ABSTRACT It is more likely that a long-term survivor will have both cardiovascular disease and cancer on account of the progress in cancer...
-
TORONTO NOTES Common Acronyms and Abbreviations Used in Medicine Common Unit Conversions Commonly Measured Laboratory Values Ethical, Legal...
-
عرض علبة 100 الجرعة 500 ملجم برينسيبس نعم الموزع أو الصانع سوثيما التركيبة ميسالازين الدرجة العلاجية مضاد للالتهابات المعوية دواعي الإست...
Translate
Blog Archive
-
►
2019
(2961)
- ► 08/18 - 08/25 (4)
- ► 08/25 - 09/01 (46)
- ► 09/01 - 09/08 (384)
- ► 09/08 - 09/15 (113)
- ► 09/15 - 09/22 (95)
- ► 10/13 - 10/20 (76)
- ► 10/27 - 11/03 (54)
- ► 11/03 - 11/10 (177)
- ► 11/10 - 11/17 (104)
- ► 11/17 - 11/24 (226)
- ► 11/24 - 12/01 (158)
- ► 12/01 - 12/08 (356)
- ► 12/08 - 12/15 (366)
- ► 12/15 - 12/22 (395)
- ► 12/22 - 12/29 (303)
- ► 12/29 - 01/05 (104)
-
►
2020
(2522)
- ► 01/05 - 01/12 (76)
- ► 01/12 - 01/19 (34)
- ► 01/19 - 01/26 (161)
- ► 01/26 - 02/02 (206)
- ► 02/02 - 02/09 (48)
- ► 02/09 - 02/16 (12)
- ► 02/16 - 02/23 (48)
- ► 02/23 - 03/01 (27)
- ► 03/01 - 03/08 (3)
- ► 03/08 - 03/15 (113)
- ► 03/15 - 03/22 (167)
- ► 03/22 - 03/29 (267)
- ► 03/29 - 04/05 (18)
- ► 04/05 - 04/12 (30)
- ► 04/12 - 04/19 (20)
- ► 04/19 - 04/26 (30)
- ► 04/26 - 05/03 (17)
- ► 05/03 - 05/10 (3)
- ► 08/30 - 09/06 (1)
- ► 09/20 - 09/27 (8)
- ► 09/27 - 10/04 (38)
- ► 10/04 - 10/11 (41)
- ► 10/11 - 10/18 (14)
- ► 10/18 - 10/25 (200)
- ► 10/25 - 11/01 (172)
- ► 11/01 - 11/08 (218)
- ► 11/08 - 11/15 (80)
- ► 11/15 - 11/22 (25)
- ► 11/22 - 11/29 (136)
- ► 11/29 - 12/06 (142)
- ► 12/06 - 12/13 (15)
- ► 12/13 - 12/20 (35)
- ► 12/20 - 12/27 (82)
- ► 12/27 - 01/03 (35)
-
►
2021
(4866)
- ► 01/10 - 01/17 (15)
- ► 01/17 - 01/24 (10)
- ► 01/24 - 01/31 (10)
- ► 01/31 - 02/07 (2)
- ► 02/14 - 02/21 (61)
- ► 02/21 - 02/28 (88)
- ► 02/28 - 03/07 (153)
- ► 03/14 - 03/21 (17)
- ► 03/28 - 04/04 (1)
- ► 04/04 - 04/11 (66)
- ► 04/11 - 04/18 (53)
- ► 04/18 - 04/25 (1)
- ► 04/25 - 05/02 (51)
- ► 05/02 - 05/09 (55)
- ► 05/09 - 05/16 (1)
- ► 05/16 - 05/23 (11)
- ► 05/23 - 05/30 (36)
- ► 05/30 - 06/06 (8)
- ► 06/13 - 06/20 (3)
- ► 06/20 - 06/27 (5)
- ► 06/27 - 07/04 (2)
- ► 07/11 - 07/18 (1)
- ► 07/18 - 07/25 (167)
- ► 07/25 - 08/01 (15)
- ► 08/01 - 08/08 (12)
- ► 08/08 - 08/15 (11)
- ► 08/15 - 08/22 (1)
- ► 08/22 - 08/29 (1)
- ► 08/29 - 09/05 (124)
- ► 09/05 - 09/12 (226)
- ► 09/12 - 09/19 (445)
- ► 09/19 - 09/26 (164)
- ► 09/26 - 10/03 (222)
- ► 10/03 - 10/10 (75)
- ► 10/10 - 10/17 (36)
- ► 10/17 - 10/24 (35)
- ► 10/24 - 10/31 (143)
- ► 10/31 - 11/07 (117)
- ► 11/07 - 11/14 (183)
- ► 11/14 - 11/21 (271)
- ► 11/21 - 11/28 (311)
- ► 11/28 - 12/05 (315)
- ► 12/05 - 12/12 (90)
- ► 12/12 - 12/19 (435)
- ► 12/19 - 12/26 (270)
- ► 12/26 - 01/02 (547)
-
►
2022
(5151)
- ► 01/02 - 01/09 (2)
- ► 01/09 - 01/16 (230)
- ► 01/16 - 01/23 (110)
- ► 01/23 - 01/30 (325)
- ► 01/30 - 02/06 (441)
- ► 02/06 - 02/13 (519)
- ► 02/13 - 02/20 (119)
- ► 02/20 - 02/27 (13)
- ► 02/27 - 03/06 (294)
- ► 03/06 - 03/13 (324)
- ► 03/13 - 03/20 (263)
- ► 03/20 - 03/27 (58)
- ► 03/27 - 04/03 (78)
- ► 04/03 - 04/10 (122)
- ► 04/10 - 04/17 (103)
- ► 04/17 - 04/24 (22)
- ► 04/24 - 05/01 (33)
- ► 05/01 - 05/08 (128)
- ► 05/08 - 05/15 (86)
- ► 06/12 - 06/19 (20)
- ► 07/10 - 07/17 (7)
- ► 07/31 - 08/07 (65)
- ► 08/28 - 09/04 (116)
- ► 09/04 - 09/11 (95)
- ► 09/11 - 09/18 (165)
- ► 09/18 - 09/25 (11)
- ► 09/25 - 10/02 (2)
- ► 10/02 - 10/09 (144)
- ► 10/09 - 10/16 (573)
- ► 10/16 - 10/23 (301)
- ► 10/23 - 10/30 (30)
- ► 10/30 - 11/06 (59)
- ► 11/06 - 11/13 (75)
- ► 11/13 - 11/20 (30)
- ► 11/20 - 11/27 (93)
- ► 11/27 - 12/04 (42)
- ► 12/04 - 12/11 (2)
- ► 12/11 - 12/18 (24)
- ► 12/18 - 12/25 (16)
- ► 12/25 - 01/01 (11)
-
►
2023
(3744)
- ► 01/01 - 01/08 (8)
- ► 01/15 - 01/22 (2)
- ► 01/22 - 01/29 (87)
- ► 01/29 - 02/05 (87)
- ► 02/05 - 02/12 (606)
- ► 02/12 - 02/19 (301)
- ► 02/19 - 02/26 (21)
- ► 02/26 - 03/05 (267)
- ► 07/09 - 07/16 (2)
- ► 07/30 - 08/06 (24)
- ► 08/13 - 08/20 (99)
- ► 08/20 - 08/27 (103)
- ► 09/03 - 09/10 (89)
- ► 09/10 - 09/17 (16)
- ► 10/01 - 10/08 (250)
- ► 10/08 - 10/15 (108)
- ► 10/29 - 11/05 (465)
- ► 11/05 - 11/12 (422)
- ► 11/19 - 11/26 (82)
- ► 11/26 - 12/03 (18)
- ► 12/03 - 12/10 (200)
- ► 12/10 - 12/17 (200)
- ► 12/17 - 12/24 (76)
- ► 12/24 - 12/31 (187)
- ► 12/31 - 01/07 (24)
-
►
2024
(1784)
- ► 02/11 - 02/18 (60)
- ► 02/18 - 02/25 (53)
- ► 02/25 - 03/03 (141)
- ► 03/03 - 03/10 (488)
- ► 03/10 - 03/17 (382)
- ► 03/17 - 03/24 (398)
- ► 03/24 - 03/31 (261)
- ► 10/06 - 10/13 (1)
-
►
2025
(3287)
- ► 02/02 - 02/09 (16)
- ► 02/16 - 02/23 (36)
- ► 03/23 - 03/30 (30)
- ► 04/27 - 05/04 (37)
- ► 05/25 - 06/01 (9)
- ► 06/01 - 06/08 (63)
- ► 06/08 - 06/15 (4)
- ► 06/15 - 06/22 (55)
- ► 09/21 - 09/28 (40)
- ► 09/28 - 10/05 (49)
- ► 10/05 - 10/12 (137)
- ► 10/12 - 10/19 (552)
- ► 10/19 - 10/26 (404)
- ► 10/26 - 11/02 (448)
- ► 11/02 - 11/09 (498)
- ► 11/09 - 11/16 (72)
- ► 11/16 - 11/23 (417)
- ► 11/23 - 11/30 (48)
- ► 11/30 - 12/07 (7)
- ► 12/14 - 12/21 (2)
- ► 12/21 - 12/28 (317)
- ► 12/28 - 01/04 (46)
-
▼
2026
(661)
- ► 01/04 - 01/11 (240)
-
▼
01/11 - 01/18
(421)
- ABSTRACTPrimary cardiac schwannoma (PCS) is a neu...
- ABSTRACTPatients treated due to mediastinal lymph...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: Benign airway stenosis (BAS) ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTIntroduction:Glioblastoma (GBM) patients ...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTBACKGROUND: GSK3368715, a first-in-class,...
- ABSTRACTLung cancer can be revealed by thromboemb...
- ABSTRACTBACKGROUND: Venous thromboembolism (VTE) ...
- ABSTRACTClinical application of doxorubicin (Dox)...
- ABSTRACTDoxorubicin (DOX) is a highly effective c...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTPatients treated due to mediastinal lymph...
- ABSTRACTBACKGROUND: Cyclic nucleotides play criti...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTBACKGROUND: GSK3368715, a first-in-class,...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTChildren with acute lymphoblastic leukemi...
- ABSTRACTThis scoping review aims to explore the r...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTPrimary cardiac schwannoma (PCS) is a neu...
- ABSTRACTThis scoping review aims to explore the r...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTPURPOSE: This study aims to construct a m...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTDoxorubicin (DOX) is a highly effective c...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTIntroduction:Glioblastoma (GBM) patients ...
- ABSTRACTLung cancer can be revealed by thromboemb...
- ABSTRACTGlioblastoma (GBM) patients have one of t...
- ABSTRACTLong-term indwelling central venous cathe...
- ABSTRACTOBJECTIVES: To compare safety and efficac...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTClinical application of doxorubicin (Dox)...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTPrimary cardiac schwannoma (PCS) is a neu...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTLung cancer can be revealed by thromboemb...
- ABSTRACTThe aim of this study was to determine wh...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTPatients treated due to mediastinal lymph...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTINTRODUCTION: Pembrolizumab is an immune ...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTDoxorubicin (DOX) is a highly effective c...
- ABSTRACTWith the continuous improvement in surviv...
- ABSTRACTChildren with acute lymphoblastic leukemi...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTBACKGROUND: Cardiac magnetic resonance (C...
- ABSTRACTCardiovascular disease is a major cause o...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTPURPOSE: Breast cancer survivors may expe...
- ABSTRACTBACKGROUND: According to current guidelin...
- ABSTRACTTo describe the population with early mal...
- ABSTRACTCancer is one of the leading causes of de...
- ABSTRACTPURPOSE: To determine the role of magneti...
- ABSTRACTBACKGROUND: Benign airway stenosis (BAS) ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTUp to 15-20% of cancer patients experienc...
- ABSTRACTBACKGROUND: Atrial fibrillation (AF) is t...
- ABSTRACTINTRODUCTION: Pembrolizumab is an immune ...
- ABSTRACTCardiovascular disease is a major cause o...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTTrastuzumab (TZB) is a new medicine, used...
- ABSTRACTDuchenne muscular dystrophy (DMD) is char...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTIntroduction:Glioblastoma (GBM) patients ...
- ABSTRACTCancer therapy-related pulmonary hyperten...
- ABSTRACTBACKGROUND: Tyrosine kinase inhibitors (T...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
Blog Archive
-
►
2019
(2961)
- ► 08/18 - 08/25 (4)
- ► 08/25 - 09/01 (46)
- ► 09/01 - 09/08 (384)
- ► 09/08 - 09/15 (113)
- ► 09/15 - 09/22 (95)
- ► 10/13 - 10/20 (76)
- ► 10/27 - 11/03 (54)
- ► 11/03 - 11/10 (177)
- ► 11/10 - 11/17 (104)
- ► 11/17 - 11/24 (226)
- ► 11/24 - 12/01 (158)
- ► 12/01 - 12/08 (356)
- ► 12/08 - 12/15 (366)
- ► 12/15 - 12/22 (395)
- ► 12/22 - 12/29 (303)
- ► 12/29 - 01/05 (104)
-
►
2020
(2522)
- ► 01/05 - 01/12 (76)
- ► 01/12 - 01/19 (34)
- ► 01/19 - 01/26 (161)
- ► 01/26 - 02/02 (206)
- ► 02/02 - 02/09 (48)
- ► 02/09 - 02/16 (12)
- ► 02/16 - 02/23 (48)
- ► 02/23 - 03/01 (27)
- ► 03/01 - 03/08 (3)
- ► 03/08 - 03/15 (113)
- ► 03/15 - 03/22 (167)
- ► 03/22 - 03/29 (267)
- ► 03/29 - 04/05 (18)
- ► 04/05 - 04/12 (30)
- ► 04/12 - 04/19 (20)
- ► 04/19 - 04/26 (30)
- ► 04/26 - 05/03 (17)
- ► 05/03 - 05/10 (3)
- ► 08/30 - 09/06 (1)
- ► 09/20 - 09/27 (8)
- ► 09/27 - 10/04 (38)
- ► 10/04 - 10/11 (41)
- ► 10/11 - 10/18 (14)
- ► 10/18 - 10/25 (200)
- ► 10/25 - 11/01 (172)
- ► 11/01 - 11/08 (218)
- ► 11/08 - 11/15 (80)
- ► 11/15 - 11/22 (25)
- ► 11/22 - 11/29 (136)
- ► 11/29 - 12/06 (142)
- ► 12/06 - 12/13 (15)
- ► 12/13 - 12/20 (35)
- ► 12/20 - 12/27 (82)
- ► 12/27 - 01/03 (35)
-
►
2021
(4866)
- ► 01/10 - 01/17 (15)
- ► 01/17 - 01/24 (10)
- ► 01/24 - 01/31 (10)
- ► 01/31 - 02/07 (2)
- ► 02/14 - 02/21 (61)
- ► 02/21 - 02/28 (88)
- ► 02/28 - 03/07 (153)
- ► 03/14 - 03/21 (17)
- ► 03/28 - 04/04 (1)
- ► 04/04 - 04/11 (66)
- ► 04/11 - 04/18 (53)
- ► 04/18 - 04/25 (1)
- ► 04/25 - 05/02 (51)
- ► 05/02 - 05/09 (55)
- ► 05/09 - 05/16 (1)
- ► 05/16 - 05/23 (11)
- ► 05/23 - 05/30 (36)
- ► 05/30 - 06/06 (8)
- ► 06/13 - 06/20 (3)
- ► 06/20 - 06/27 (5)
- ► 06/27 - 07/04 (2)
- ► 07/11 - 07/18 (1)
- ► 07/18 - 07/25 (167)
- ► 07/25 - 08/01 (15)
- ► 08/01 - 08/08 (12)
- ► 08/08 - 08/15 (11)
- ► 08/15 - 08/22 (1)
- ► 08/22 - 08/29 (1)
- ► 08/29 - 09/05 (124)
- ► 09/05 - 09/12 (226)
- ► 09/12 - 09/19 (445)
- ► 09/19 - 09/26 (164)
- ► 09/26 - 10/03 (222)
- ► 10/03 - 10/10 (75)
- ► 10/10 - 10/17 (36)
- ► 10/17 - 10/24 (35)
- ► 10/24 - 10/31 (143)
- ► 10/31 - 11/07 (117)
- ► 11/07 - 11/14 (183)
- ► 11/14 - 11/21 (271)
- ► 11/21 - 11/28 (311)
- ► 11/28 - 12/05 (315)
- ► 12/05 - 12/12 (90)
- ► 12/12 - 12/19 (435)
- ► 12/19 - 12/26 (270)
- ► 12/26 - 01/02 (547)
-
►
2022
(5151)
- ► 01/02 - 01/09 (2)
- ► 01/09 - 01/16 (230)
- ► 01/16 - 01/23 (110)
- ► 01/23 - 01/30 (325)
- ► 01/30 - 02/06 (441)
- ► 02/06 - 02/13 (519)
- ► 02/13 - 02/20 (119)
- ► 02/20 - 02/27 (13)
- ► 02/27 - 03/06 (294)
- ► 03/06 - 03/13 (324)
- ► 03/13 - 03/20 (263)
- ► 03/20 - 03/27 (58)
- ► 03/27 - 04/03 (78)
- ► 04/03 - 04/10 (122)
- ► 04/10 - 04/17 (103)
- ► 04/17 - 04/24 (22)
- ► 04/24 - 05/01 (33)
- ► 05/01 - 05/08 (128)
- ► 05/08 - 05/15 (86)
- ► 06/12 - 06/19 (20)
- ► 07/10 - 07/17 (7)
- ► 07/31 - 08/07 (65)
- ► 08/28 - 09/04 (116)
- ► 09/04 - 09/11 (95)
- ► 09/11 - 09/18 (165)
- ► 09/18 - 09/25 (11)
- ► 09/25 - 10/02 (2)
- ► 10/02 - 10/09 (144)
- ► 10/09 - 10/16 (573)
- ► 10/16 - 10/23 (301)
- ► 10/23 - 10/30 (30)
- ► 10/30 - 11/06 (59)
- ► 11/06 - 11/13 (75)
- ► 11/13 - 11/20 (30)
- ► 11/20 - 11/27 (93)
- ► 11/27 - 12/04 (42)
- ► 12/04 - 12/11 (2)
- ► 12/11 - 12/18 (24)
- ► 12/18 - 12/25 (16)
- ► 12/25 - 01/01 (11)
-
►
2023
(3744)
- ► 01/01 - 01/08 (8)
- ► 01/15 - 01/22 (2)
- ► 01/22 - 01/29 (87)
- ► 01/29 - 02/05 (87)
- ► 02/05 - 02/12 (606)
- ► 02/12 - 02/19 (301)
- ► 02/19 - 02/26 (21)
- ► 02/26 - 03/05 (267)
- ► 07/09 - 07/16 (2)
- ► 07/30 - 08/06 (24)
- ► 08/13 - 08/20 (99)
- ► 08/20 - 08/27 (103)
- ► 09/03 - 09/10 (89)
- ► 09/10 - 09/17 (16)
- ► 10/01 - 10/08 (250)
- ► 10/08 - 10/15 (108)
- ► 10/29 - 11/05 (465)
- ► 11/05 - 11/12 (422)
- ► 11/19 - 11/26 (82)
- ► 11/26 - 12/03 (18)
- ► 12/03 - 12/10 (200)
- ► 12/10 - 12/17 (200)
- ► 12/17 - 12/24 (76)
- ► 12/24 - 12/31 (187)
- ► 12/31 - 01/07 (24)
-
►
2024
(1784)
- ► 02/11 - 02/18 (60)
- ► 02/18 - 02/25 (53)
- ► 02/25 - 03/03 (141)
- ► 03/03 - 03/10 (488)
- ► 03/10 - 03/17 (382)
- ► 03/17 - 03/24 (398)
- ► 03/24 - 03/31 (261)
- ► 10/06 - 10/13 (1)
-
►
2025
(3287)
- ► 02/02 - 02/09 (16)
- ► 02/16 - 02/23 (36)
- ► 03/23 - 03/30 (30)
- ► 04/27 - 05/04 (37)
- ► 05/25 - 06/01 (9)
- ► 06/01 - 06/08 (63)
- ► 06/08 - 06/15 (4)
- ► 06/15 - 06/22 (55)
- ► 09/21 - 09/28 (40)
- ► 09/28 - 10/05 (49)
- ► 10/05 - 10/12 (137)
- ► 10/12 - 10/19 (552)
- ► 10/19 - 10/26 (404)
- ► 10/26 - 11/02 (448)
- ► 11/02 - 11/09 (498)
- ► 11/09 - 11/16 (72)
- ► 11/16 - 11/23 (417)
- ► 11/23 - 11/30 (48)
- ► 11/30 - 12/07 (7)
- ► 12/14 - 12/21 (2)
- ► 12/21 - 12/28 (317)
- ► 12/28 - 01/04 (46)
-
▼
2026
(661)
- ► 01/04 - 01/11 (240)
-
▼
01/11 - 01/18
(421)
- ABSTRACTPrimary cardiac schwannoma (PCS) is a neu...
- ABSTRACTPatients treated due to mediastinal lymph...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: Benign airway stenosis (BAS) ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTIntroduction:Glioblastoma (GBM) patients ...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTBACKGROUND: GSK3368715, a first-in-class,...
- ABSTRACTLung cancer can be revealed by thromboemb...
- ABSTRACTBACKGROUND: Venous thromboembolism (VTE) ...
- ABSTRACTClinical application of doxorubicin (Dox)...
- ABSTRACTDoxorubicin (DOX) is a highly effective c...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTPatients treated due to mediastinal lymph...
- ABSTRACTBACKGROUND: Cyclic nucleotides play criti...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTBACKGROUND: GSK3368715, a first-in-class,...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTChildren with acute lymphoblastic leukemi...
- ABSTRACTThis scoping review aims to explore the r...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTPrimary cardiac schwannoma (PCS) is a neu...
- ABSTRACTThis scoping review aims to explore the r...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTPURPOSE: This study aims to construct a m...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTDoxorubicin (DOX) is a highly effective c...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTIntroduction:Glioblastoma (GBM) patients ...
- ABSTRACTLung cancer can be revealed by thromboemb...
- ABSTRACTGlioblastoma (GBM) patients have one of t...
- ABSTRACTLong-term indwelling central venous cathe...
- ABSTRACTOBJECTIVES: To compare safety and efficac...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTClinical application of doxorubicin (Dox)...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTPrimary cardiac schwannoma (PCS) is a neu...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTLung cancer can be revealed by thromboemb...
- ABSTRACTThe aim of this study was to determine wh...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTBackground. The most important anthracycl...
- ABSTRACTPatients treated due to mediastinal lymph...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTINTRODUCTION: Pembrolizumab is an immune ...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTAIM: To explore the diverse profiles of a...
- ABSTRACTDoxorubicin (DOX) is a highly effective c...
- ABSTRACTWith the continuous improvement in surviv...
- ABSTRACTChildren with acute lymphoblastic leukemi...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTBACKGROUND: Cardiac magnetic resonance (C...
- ABSTRACTCardiovascular disease is a major cause o...
- ABSTRACTBACKGROUND: Doxorubicin (Doxo) is a widel...
- ABSTRACTPURPOSE: Breast cancer survivors may expe...
- ABSTRACTBACKGROUND: According to current guidelin...
- ABSTRACTTo describe the population with early mal...
- ABSTRACTCancer is one of the leading causes of de...
- ABSTRACTPURPOSE: To determine the role of magneti...
- ABSTRACTBACKGROUND: Benign airway stenosis (BAS) ...
- ABSTRACT(1) Background: Cancer treatment, includi...
- ABSTRACTCardiac tumors are a heterogeneous group ...
- ABSTRACTUp to 15-20% of cancer patients experienc...
- ABSTRACTBACKGROUND: Atrial fibrillation (AF) is t...
- ABSTRACTINTRODUCTION: Pembrolizumab is an immune ...
- ABSTRACTCardiovascular disease is a major cause o...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
- ABSTRACTTrastuzumab (TZB) is a new medicine, used...
- ABSTRACTDuchenne muscular dystrophy (DMD) is char...
- ABSTRACTINTRODUCTION: Direct oral anticoagulants ...
- ABSTRACTBACKGROUND: The incidence of venous throm...
- ABSTRACTIntroduction:Glioblastoma (GBM) patients ...
- ABSTRACTCancer therapy-related pulmonary hyperten...
- ABSTRACTBACKGROUND: Tyrosine kinase inhibitors (T...
- ABSTRACTPURPOSE OF REVIEW: Although mortality rat...
- ABSTRACTDoxorubicin (Dox) is a highly potent chem...
Featured Post
ABSTRACT Doxorubicin (Dox) is a highly potent chemotherapy drug. Despite its efficacy, Dox's clinical application is limited due to it...























